Upgrade to SI Premium - Free Trial

CervoMed (CRVO)

2.57 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Form 8-K CervoMed Inc. For: Sep 10 September 10, 2026 4:08 PM - SEC Filing CervoMed nfvPPA trial data to be presented at ISFTD meeting September 10, 2026 7:30 AM - StreetInsider CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFT September 10, 2026 7:30 AM - StreetInsider CervoMed to Participate in September Investor Conferences September 8, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G/A CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. August 14, 2026 4:48 PM - SEC Filing Form SCHEDULE 13G/A CervoMed Inc. Filed by: CVI Investments, Inc. August 14, 2026 2:42 PM - SEC Filing Form SCHEDULE 13G CervoMed Inc. Filed by: Woodline Partners LP August 14, 2026 11:03 AM - SEC Filing Form SCHEDULE 13G CervoMed Inc. Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:09 AM - SEC Filing CervoMed (CRVO) PT Lowered to $12 at Jones Trading August 10, 2026 4:36 PM - StreetInsider Form 8-K CervoMed Inc. For: Aug 10 August 10, 2026 4:08 PM - SEC Filing CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates August 10, 2026 7:30 AM - StreetInsider CervoMed (CRVO) PT Lowered to $18 at Canaccord August 10, 2026 7:00 AM - StreetInsider Form S-8 CervoMed Inc. August 7, 2026 4:55 PM - SEC Filing Form 10-Q CervoMed Inc. For: Jun 30 August 7, 2026 4:27 PM - SEC Filing CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference August 5, 2026 7:30 AM - StreetInsider Form 8-K CervoMed Inc. For: Aug 04 August 4, 2026 7:52 AM - SEC Filing CervoMed's neflamapimod receives UK innovation passport for DLB August 4, 2026 6:00 AM - StreetInsider CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) August 4, 2026 5:15 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO) July 15, 2026 7:40 AM - StreetInsider Form 8-K CervoMed Inc. For: Jul 14 July 14, 2026 4:21 PM - SEC Filing CervoMed presents neflamapimod DLB trial data at AAIC 2026 July 14, 2026 7:32 AM - StreetInsider CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB) July 14, 2026 7:30 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO) July 13, 2026 6:40 AM - StreetInsider Form EFFECT CervoMed Inc. July 13, 2026 6:02 AM - SEC Filing Form 424B3 CervoMed Inc. July 10, 2026 5:27 PM - SEC Filing Form 8-K CervoMed Inc. For: Jul 09 July 9, 2026 4:10 PM - SEC Filing CervoMed completes enrollment in Phase 2 nfvPPA dementia trial July 9, 2026 7:30 AM - StreetInsider CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia July 9, 2026 7:30 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO) July 9, 2026 6:53 AM - StreetInsider Form SCHEDULE 13G/A CervoMed Inc. Filed by: MORGAN STANLEY July 8, 2026 5:43 PM - SEC Filing CervoMed (CRVO) for 10.08M share offering by selling stockholders July 6, 2026 5:05 PM - StreetInsider Form S-3 CervoMed Inc. July 6, 2026 5:01 PM - SEC Filing CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026 July 6, 2026 7:30 AM - Globe NewsWire CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026 July 6, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G CervoMed Inc. Filed by: CVI Investments, Inc. June 26, 2026 10:00 AM - SEC Filing Form 8-K CervoMed Inc. For: Jun 22 June 22, 2026 4:13 PM - SEC Filing CervoMed closes $10M stock offering at $4.00 per share June 22, 2026 4:05 PM - StreetInsider CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules June 22, 2026 4:05 PM - StreetInsider Form 424B5 CervoMed Inc. June 22, 2026 6:16 AM - SEC Filing Form 8-K CervoMed Inc. For: Jun 18 June 22, 2026 6:02 AM - SEC Filing CervoMed raises $10 million in registered direct stock offering June 18, 2026 12:35 PM - StreetInsider CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules June 18, 2026 12:35 PM - Globe NewsWire Form 8-K CervoMed Inc. For: Jun 16 June 18, 2026 7:22 AM - SEC Filing CervoMed receives U.S. patent for neflamapimod in pure DLB to 2042 June 18, 2026 7:00 AM - StreetInsider CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042 June 18, 2026 7:00 AM - StreetInsider Wall Street Chases the Next Big Breakout June 16, 2026 3:23 PM - StreetInsider Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum June 16, 2026 10:19 AM - StreetInsider Full Article List